INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 19, 2012 |
SVP Finance and Admin CFO Trea
Trans History: 645
|
SVP Finance and Admin CFO Trea | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,800 | $20.32 | 130,161 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 24,636 | $20.95 | 130,651 |
| Jan 03, 2011 |
Director
Trans History: 742
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 8,957 | $34.04 | 131,555 |
| Oct 27, 2009 |
Director, CEO and President, Ten Percent Owner
Trans History: 404
|
Director, CEO and President, Ten Percent Owner | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 31,611 | $10.44 | 132,058 |
| Feb 14, 2012 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 7,566 | $111.01 | 132,757 |
| Nov 13, 2012 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5,000 | $148.00 | 132,772 |
| Jun 09, 2010 |
Director
Trans History: 320
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,000 | $25.43 | 132,772 |
| Sep 06, 2011 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 82,818 | $11.64 | 133,168 |
| Jan 05, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 628
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 3,430 | -- | 133,332 |
| Nov 29, 2012 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 1,800 | $175.95 | 133,776 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.